Connect
MJA
MJA

Pharmaceutical preparations

Letters

Systematic postmarketing surveillance needed for misused psychoactive pharmaceutical drugs

Tracy W Soh

Med J Aust 2013; 199 (11): 746

Letters

Systematic postmarketing surveillance needed for misused psychoactive pharmaceutical drugs

Steven Moylan

Med J Aust 2013; 199 (11): 746-747

Letters

Systematic postmarketing surveillance needed for misused psychoactive pharmaceutical drugs

Angela C Rintoul and Malcolm D H Dobbin

Med J Aust 2013; 199 (11): 747

Letters

Inadvertent dispensing of Coumadin instead of Coversyl

Duncan P Carradice and Ellen L Maxwell

Med J Aust 2013; 199 (11): 750

Letters

Sotalol-associated cardiogenic shock in a patient with asymptomatic transient rate-related cardiomyopathy

Simon D Leslie

Med J Aust 2013; 199 (10): 658-659

Letters

Psychotropic medication in pregnancy

Roisin N Worsley, Heather Gilbert and Jayashri Kulkarni

Med J Aust 2013; 199 (10): 661

Research

Low awareness of adverse drug reaction reporting systems: a consumer survey

Jane Robertson and David A Newby

Med J Aust 2013; 199 (10): 684-686 Free

Case reports

Pregabalin-associated rhabdomyolysis

Roshan Gunathilake, Laura E Boyce and Anne T Knight

Med J Aust 2013; 199 (9): 624-625 Free

Supplement – Clinical Focus

Pharmacological treatment approaches to difficult-to-treat depression

Herng-Nieng Chan, Philip B Mitchell, Colleen K A Loo and Samuel B Harvey

Med J Aust 2013; 199 (6): S44-S47 Free

Case reports

Khat-associated hepatitis

Malcolm P Forbes, Ashok S Raj, Jennifer Martin, Guy Lampe and Elizabeth E Powell

Med J Aust 2013; 199 (7): 498-499 Free

Letters

Vitamin D and health in adults in Australia and New Zealand

Caryl A Nowson and Rebecca S Mason

Med J Aust 2013; 199 (6): 394

Perspectives

The after-life of drugs: a responsible care initiative for reducing their environmental impact

Peter M J Fisher, David A Smith and Peter J Collignon

Med J Aust 2013; 199 (6): 388-390 Free

Letters

Vitamin D and health in adults in Australia and New Zealand

Bettina Douglas

Med J Aust 2013; 199 (6): 394

Letters

Severe symptomatic hypocalcaemia following a single dose of denosumab

Jennifer M McLachlan, Gavin M Marx and Margaret Bridgman

Med J Aust 2013; 199 (4): 242-243

For debate

Trials and tribulations in the removal of dextropropoxyphene from the Australian Register of Therapeutic Goods

Nick A Buckley and Thomas A Faunce

Med J Aust 2013; 199 (4): 257-260 Free

Letters

Rethinking psychotropics in nursing homes

Sarah N Hilmer and Danijela Gnjidic

Med J Aust 2013; 199 (2): 99

Editorials

How can we improve access to new (and old) antibiotics in Australia?

Allen C Cheng and Roger L Nation

Med J Aust 2013; 199 (2): 81-82

Letters

Rethinking psychotropics in nursing homes

Juanita L Westbury and Gregory M Peterson

Med J Aust 2013; 199 (2): 98

Letters

Rethinking psychotropics in nursing homes

Ludomyr J Mykyta

Med J Aust 2013; 199 (2): 98-99

Reflections

The case for CBT over antidepressants

Kay A Wilhelm

Med J Aust 2013; 198 (9): 507

Clinical focus

Mass or molar? Recommendations for reporting concentrations of therapeutic drugs

Graham R D Jones, Stewart Bryant, Robert Fullinfaw, Ken Ilett, John O Miners, Raymond G Morris and Matthew P Doogue

Med J Aust 2013; 198 (7): 368-369 Free

Perspectives

Is there really misuse and abuse of dabigatran?

John W Eikelboom and Graeme J Hankey

Med J Aust 2013; 198 (7): 358-359 Free

Letters

The pricing of statins and implications for Pharmaceutical Benefits Scheme expenditure

Philip M Clarke

Med J Aust 2013; 198 (5): 260

Research

Prescribing trends before and after implementation of an antimicrobial stewardship program

Kelly A Cairns, Adam W J Jenney, Iain J Abbott, Matthew J Skinner, Joseph S Doyle, Michael Dooley and Allen C Cheng

Med J Aust 2013; 198 (5): 262-266 Free

Perspectives

Rethinking psychotropics in nursing homes

Sarah N Hilmer and Danijela Gnjidic

Med J Aust 2013; 198 (2): 77